Back

Angiotensin II formulations and their impact on reproducibility, reduction and refinement (3R) of the animal models of hypertension.

29 April 2022 (00:00 - 00:00)
Organised by: Logo
Congress Presentation Part of: Late-Breaking Science - Poster session 2 Basic Science, Other CBS PREMIUM ACCESS Frontiers in CardioVascular Biomedicine 2022 Council on Basic Cardiovascular Science

About the speaker

Photo
Doctor Ryszard Nosalski

Queen's Medical Research Institute, Edinburgh (United Kingdom of Great Britain & Northern Ireland)

4 More presentations in this session

Presentation thumbnail
Beta-catenin C-terminus signaling promotes neointimal formation after vascular injury by inducing the sphingosine-1 phosphate receptor-1 expression
Doctor G. Oliveira-Paula (Abilene, US)
Presentation thumbnail
Mapping the low-density lipoprotein interactome in mouse atherosclerosis
Mrs R. Muniz (Madrid, ES)
Presentation thumbnail
Tissue engineered vascular patch fabrication using hybrid 3D printing and electrospinning
Doctor E. Bevilacqua (Seville, ES)
Presentation thumbnail
Ranolazine induced modulation of intracellular Na+ concentration impacts inflammatory response and reduces atherosclerotic plaque progression
Doctor M. Lenz (Vienna, AT)

Access the full session

Session thumbnail
Late-Breaking Science - Poster session 2

The Event

Event poster

Frontiers in CardioVascular Biomedicine 2022

29 April - 1 May 2022

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources